GOUT RELIEF 3310A PLUS tablet

Gout Relief 3310A Plus by

Drug Labeling and Warnings

Gout Relief 3310A Plus by is a Homeopathic medication manufactured, distributed, or labeled by Bispit Canada Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

MEDICAGO SATIVA WHOLE
CHICORY ROOT
GLUCOSAMINE HYDROCHLORIDE
BUCKWHEAT
TEA LEAF
MORUS ALBA LEAF
LICORICE
FU LING
COIX LACRYMA-JOBI SEED
ANSERINE

INACTIVE INGREDIENT

CALCIUM CARBONATE
SODIUM CHLORIDE

WARNINGS

Ulsing three bottles is generally effective fordissolving crystals (as crystal dissoiution takestime);
You should experience noticeable effects afterat least 21 days of conbnlous use,It is noral to experence increose in uric acidlevels or gout recurrencelchanges imn affectedareas during the early days of use;Refrain from olcohol consumption, or limit itsionificantly, for at least 15 days before takingthis product;
lt has an auxiliary effect on improving libidoand supporting prostate health,
Do not use if you have a seafood allergy.
Store properly and out of reach of children.

KEEP OUT OF REACH OF CHILDREN

Store properly and out of reach of children.

PURPOSE

This product is a pure plant extract; it canreduce the frequency of goutattacks; dissolve the crystals in thejoints; promote the excretion of blood uricacids,andimprove the purine metabolismand excretory system.

DOSAGE & ADMINISTRATION

2 tablets in the momingand 2 toblets in the evening.

INDICATIONS & USAGE

Applicable Population:patient with gout,high uric acid, depositionof urate crystal, kidney stone and bladder
stone.

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

GOUT RELIEF 3310A PLUS 
gout relief 3310a plus tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 85631-009
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LICORICE (UNII: 61ZBX54883) (LICORICE - UNII:61ZBX54883)	LICORICE	1 mg  in 1 g
MEDICAGO SATIVA WHOLE (UNII: DJO934BRBD) (MEDICAGO SATIVA WHOLE - UNII:DJO934BRBD)	MEDICAGO SATIVA WHOLE	150 mg  in 1 g
BUCKWHEAT (UNII: N0Y68724R3) (BUCKWHEAT - UNII:N0Y68724R3)	BUCKWHEAT	40 mg  in 1 g
FU LING (UNII: XH37TWY5O4) (FU LING - UNII:XH37TWY5O4)	FU LING	10 mg  in 1 g
CHICORY ROOT (UNII: 090CTY533N) (CHICORY ROOT - UNII:090CTY533N)	CHICORY ROOT	180 mg  in 1 g
MORUS ALBA LEAF (UNII: M8YIA49Q2P) (MORUS ALBA LEAF - UNII:M8YIA49Q2P)	MORUS ALBA LEAF	75 mg  in 1 g
ANSERINE (UNII: HDQ4N37UGV) (ANSERINE - UNII:HDQ4N37UGV)	ANSERINE	350 mg  in 1 g
TEA LEAF (UNII: GH42T47V24) (TEA LEAF - UNII:GH42T47V24)	TEA LEAF	34 mg  in 1 g
COIX LACRYMA-JOBI SEED (UNII: 4Q4V6NTZ1F) (COIX LACRYMA-JOBI SEED - UNII:4Q4V6NTZ1F)	COIX LACRYMA-JOBI SEED	40 mg  in 1 g
GLUCOSAMINE HYDROCHLORIDE (UNII: 750W5330FY) (GLUCOSAMINE - UNII:N08U5BOQ1K)	GLUCOSAMINE HYDROCHLORIDE	70 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
CALCIUM CARBONATE (UNII: H0G9379FGK)
SODIUM CHLORIDE (UNII: 451W47IQ8X)

Product Characteristics
Color	brown	Score	score with uneven pieces
Shape	ROUND	Size	14mm
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 85631-009-01	60 in 1 BOX	09/05/2025
1		1 g in 1 CAPSULE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved homeopathic		09/05/2025

Labeler - Bispit Canada Ltd. (243332192)

Registrant - Bispit Canada Ltd. (243332192)